CN Stock MarketDetailed Quotes
301211 Hubei Biocause Heilen Pharmaceutical
- 19.92
- -1.07-5.10%
Post Market Nov 18 15:00 CST
5.74BMarket Cap53.98P/E (TTM)
21.00High19.81Low54.41KlotVolume20.81Open20.99Pre Close109.89MTurnover7.56%Turnover Ratio32.55P/E (Static)288.00MShares26.4752wk High2.50P/B1.43BFloat Cap13.5752wk Low25.19Limit Up72.00MShs Float46.06Historical High16.79Limit Down5.67%Amplitude12.48Historical Low0.48Dividend TTM20.20Avg Price30.42KlotAsk2.41%Div YieldTTM100Lot Size21.35KlotBid
Hubei Biocause Heilen Pharmaceutical Key Stats
EPS
According to the latest financial report of Hubei Biocause Heilen Pharmaceutical, the latest earnings per share (TTM) for the company is 0.26. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Hubei Biocause Heilen Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 7.97.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Hubei Biocause Heilen Pharmaceutical shows that the company's current ratio is 14.62, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Hubei Biocause Heilen Pharmaceutical, the quick ratio is 13.41, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Hubei Biocause Heilen Pharmaceutical? The latest ROE figure is 3.21%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Hubei Biocause Heilen Pharmaceutical, the total asset return on investment (ROA) is 3.00%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Hubei Biocause Heilen Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 30.23%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Hubei Biocause Heilen Pharmaceutical, the net profit margin is 22.35%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data